Calibration of prior variance in the Bayesian continual reassessment method
暂无分享,去创建一个
[1] A Kramar,et al. A comparison of model choices for the continual reassessment method in phase I cancer trials , 2009, Statistics in medicine.
[2] J O'Quigley,et al. Continual reassessment method: a practical design for phase 1 clinical trials in cancer. , 1990, Biometrics.
[3] Ying Kuen Cheung,et al. A Simple Technique to Evaluate Model Sensitivity in the Continual Reassessment Method , 2002, Biometrics.
[4] S Chevret,et al. The continual reassessment method in cancer phase I clinical trials: a simulation study. , 1993, Statistics in medicine.
[5] Ying Kuen Cheung,et al. Coherence principles in dose-finding studies , 2005 .
[6] Shing M. Lee,et al. Model calibration in the continual reassessment method , 2009, Clinical trials.
[7] J O'Quigley,et al. Continual reassessment method: a likelihood approach. , 1996, Biometrics.
[8] J. Vose,et al. Phase I/II Trial of Bortezomib + CHOP-Rituximab in Diffuse Large B Cell (DLBCL) and Mantle Cell Lymphoma (MCL): Phase I Results. , 2005 .
[9] Y K Cheung,et al. Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities , 2000, Biometrics.
[10] Ying Yuan,et al. Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials , 2009 .